grant

Near patient detection of pathogenic candida species directly from blood and urine for rapid treatment response

Organization JOHNS HOPKINS UNIVERSITYLocation BALTIMORE, UNITED STATESPosted 1 Aug 2025Deadline 30 Jun 2030
NIHUS FederalResearch GrantFY2025AllelesAllelomorphsAmBAmBisomeAmphocilAmphotecAmphotercin BAmphotericin BAssayAutomationBioassayBiological AssayBloodBlood CirculationBlood Reticuloendothelial SystemBlood SampleBlood TestsBlood VolumeBlood specimenBloodstreamC albicansC aurisC. Auris resistanceC. albicansC. aurisC. glabrataC.albicansCandidaCandida albicansCandida aurisCandida glabrataClinicalClinical TrialsCodeCoding SystemCollaborationsCommunicable DiseasesDNA SequenceDetectionDevelopmentDiagnosisDiagnostic testsDrug TargetingDrug resistanceFibrinFungal Drug ResistanceFungizoneFungus DiseasesFungus drug resistantHematologic TestsHematological TestsHematology TestingHot SpotImmunocompromisedImmunocompromised HostImmunocompromised PatientImmunosuppressed HostIndividualInfectionInfection ControlInfectious DiseasesInfectious DisorderLaboratoriesLifeMagnetic ResonanceMedical Care CostsMethodsMolecularMoniliaMulti-Drug ResistanceMultidrug ResistanceMultiple Drug ResistanceMultiple Drug ResistantMycosesMysteclin-FNested PCRNested Polymerase Chain ReactionNucleic AcidsPathogenicityPatient CarePatient Care DeliveryPatientsPerformancePredispositionPreparationProcessReactionReagentReflexReflex actionReportingResistanceResistance to Multi-drugResistance to MultidrugResistance to Multiple DrugResistant to Multiple DrugResistant to multi-drugResistant to multidrugRiskSamplingSensitivity and SpecificitySpecificitySusceptibilityTechnologyTemperatureTestingTherapeutic FungicidesTimeTorulopsis glabrataTrainingUnited StatesUrinary tract infectionUrinary tract infectious diseaseUrineValidationVirulentamplification and detectionamplification detectionanti-fungalanti-fungal agentsanti-fungal druganti-fungal drug resistanceanti-fungal drug resistantanti-fungal resistanceanti-fungal resistantbasebasesblood infectionbloodstream infectioncandidaemiacandidemiacare for patientscare of patientscaring for patientsclinical relevanceclinical validationclinically relevantdetection assaydetection of amplificationdevelopmentaldiagnostic assaydrug resistantechinocandin resistanceechinocandin resistanteffective therapyeffective treatmentexperiencefungal infectionfungal pathogenfungi pathogenfungus drug resistancefungus infectionimmunosuppressed patientimprovedinfection in the bloodinfection of the bloodinnovateinnovationinnovativemedical costsmedical expensesmeltingmortalitymulti-drug resistantmultidrug resistantnew approachesnovel approachesnovel strategiesnovel strategypathogenic funguspoint of carepoint-of-care diagnosticspre-clinical studypreclinical studypreparationsrapid detectionrapid diagnosisrapid methodrapid techniqueresistance development in C. Aurisresistance in C. aurisresistance in Candida aurisresistance to Drugresistance to anti-fungalresistantresistant Candida aurisresistant to Drugresistant to anti-fungalresponse to therapyresponse to treatmenttesting accesstherapeutic responsetherapy responsetreatment responsetreatment responsivenessurinary infectionuser-friendlyvalidations
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

ABSTRACT
Fungal species are among the most common causes of nosocomial bloodstream and invasive infections in

immunocompromised hosts. Mortality from candidemia can be very high, ranging from 20-40%. The global

emergence of virulent multidrug resistant species such as Candida auris, with a mortality reported to be as high

as 68% is particularly…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Near patient detection of pathogenic candida species directly from blood and urine for rapid treatment response — JOHNS | Dev Procure